Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Azarga Gets Thumbs Up from Analysts After Favorable Ruling on NRC License

After receiving a favorable ruling on the NRC license, its focus shifts to project economics. Azarga Uranium Corp. (AZZ:TSX; AZZUF:OTCQB; P8AA:FSE) recently announced that the Atomic Safety and Licensing Board (ASLB) issued its Final Initial Decision, resolving the...
Streetwise Reports | December 27, 2019 |

US Stock Markets Trade Sideways – Waiting on News/Guidance.

Our researchers believe the global concerns centered around Banking and Debt within the Emerging Markets and Asia/Europe are very likely to become major issues over the next 3+ months. These potentially dangerous issues could have far-reaching pricing ramifications for almost ...
Chris Vermeulen | October 8, 2019 |

Axsome Therapeutics Shares Open 82% Higher on Phase 3 MDD Trial Outcome

Axsome Therapeutics shares reached a new 52-week high price today after the company reported that its AXS-05 drug achieved primary endpoint in the GEMINI Phase 3 trial in Major Depressive Disorder. The firm indicated that the positive results support a New Drug Application fil...
Streetwise Reports | December 17, 2019 |

FansUnite Launches a High-Growth Consolidation Strategy Targeting the Games We Play Indoors

This company, active in the gaming industry since 2014, has just gone public and is looking to unleash its own high-growth consolidation strategy. Lets face it: gamers love games. While currently there's a dearth of real sports activity, that doesn't mean pe...
Streetwise Reports | May 6, 2020 |

Interview with Lukas Lundin

“One drill hole changes the game. It’s very hard to decide who gets to make it and who doesn’t. It’s a big gate, and yet very few make it through. But you have to let them try.” — Lukas Lundin ...
Tommy Humphreys | May 6, 2013 |

Coronavirus And The Coming Financial Revolution

The coronavirus pandemic is one of the biggest and unprecedented seismic shifts in the global economy that we've ever seen in modern history, and it's just getting started. Already, economies around the world are shutting down. The federal reserve has pumped trillions int...
Michael Kern | April 15, 2020 |

Iron Ore & Vanadium in Quebec: Who’s Driving BOTH Markets?

(Click image to play podcast) One of the world’s least known metals also happens to be of immense importance and is likely to become even more so as renewable energies catch up with and, eventually, eclipse fossil fuels. If you don&CloseCurlyQ...
Dave Jackson | October 19, 2020 |

This China sector is ramping up

Share | "Are you sure this is one of the top hospitals in Beijing? The paint's peeling!" This was my reaction after spending five minutes in a Chinese hospital. I asked our associate to do his best to snap some pictures without anyone noticing. (When your...
Larsen Kusick | October 28, 2012 |

Seabed rare earth and precious metal mining

Rising prices in precious metals and China’s monopoly in rare earth elements are leading to creativity and innovation in mining. For instance, Japan reported last month that they found extremely rich deposits of rare earth minerals on the seabed of the Pa...
Justin Dove | October 28, 2012 |

Reata Pharma Announces $350 Million Strategic Investment from Blackstone Life Sciences

Shares of Reata Pharmaceuticals traded 30% higher after reporting that Blackstone Life Sciences will invest $350 million in the company to advance bardoxolone methyl as a potential therapy for Alport syndrome and other rare and serious chronic kidney diseases. Clin...
Streetwise Reports | June 12, 2020 |
1 2 3 4 5 6 7 8 9 10 ...